Depression Treatment
Understanding Depression
Depression is far more than ordinary sadness. It is a complex neurobiological disorder that affects approximately 280 million people worldwide, making it one of the leading causes of disability globally according to the World Health Organization.
Depression, clinically referred to as Major Depressive Disorder (MDD), is a serious medical condition rooted in measurable changes in brain chemistry, neural circuitry, and neuroendocrine function. Research using functional MRI and PET scanning has revealed that individuals with depression show altered activity in the prefrontal cortex, amygdala, hippocampus, and anterior cingulate cortex. These neurological changes are not a matter of willpower or personal weakness -- they are medical realities that respond to targeted, evidence-based treatment.
At RECO Integrated Psychiatry, we approach depression as the multifactorial condition it is. We understand that genetics, neurotransmitter imbalances involving serotonin, norepinephrine, and dopamine, neuroplasticity deficits, inflammatory processes, and psychosocial stressors all contribute to its onset and persistence. This understanding allows us to create treatment plans that address the full spectrum of contributing factors rather than relying on a single modality.
Types of Depression We Treat
Major Depressive Disorder (MDD)
The most commonly diagnosed form of depression, MDD is characterized by persistent depressive episodes lasting at least two weeks. It affects approximately 8.3% of American adults -- roughly 21 million people -- in any given year. MDD can range from mild to severe and may present as a single episode or recurrent pattern. Without treatment, episodes typically last 6 to 12 months, and the likelihood of recurrence increases with each untreated episode. According to NIMH data, women are nearly twice as likely to experience MDD compared to men, and the condition most commonly first appears between ages 18 and 25.
Persistent Depressive Disorder (PDD)
Formerly known as dysthymia, PDD involves a chronically depressed mood lasting for at least two years in adults or one year in children and adolescents. While symptoms may be less severe than MDD at any given moment, the prolonged duration can be equally debilitating. Many individuals with PDD describe feeling as though they have been depressed for as long as they can remember. PDD affects approximately 1.5% of the adult population. It often goes undiagnosed because patients and even some clinicians mistake the chronic low mood for a person's baseline personality rather than recognizing it as a treatable condition.
Seasonal Affective Disorder (SAD)
SAD is a type of depression that follows a seasonal pattern, most commonly occurring during fall and winter months when daylight exposure decreases. It affects approximately 5% of the U.S. adult population, with episodes lasting about 40% of the year. SAD is thought to be linked to disruptions in circadian rhythm, melatonin production, and serotonin levels related to reduced sunlight exposure. While it may be less prevalent in South Florida's sunny climate, it still occurs and can be exacerbated by lifestyle factors. Treatment may include light therapy, medication adjustments, and targeted psychotherapy.
The Neuroscience of Depression
Modern neuroscience has dramatically expanded our understanding of depression beyond the simple "chemical imbalance" theory. While neurotransmitter dysregulation involving serotonin, norepinephrine, and dopamine remains an important factor, researchers now recognize that depression involves complex interactions between multiple biological systems.
Neuroplasticity -- the brain's ability to form new neural connections -- is significantly impaired in depression. Studies show that the hippocampus, a brain region critical for memory and emotional regulation, can actually shrink in volume during prolonged depressive episodes. This is linked to reduced levels of Brain-Derived Neurotrophic Factor (BDNF), a protein essential for neuronal growth and survival. Encouraging research shows that effective treatments, including both antidepressant medications and therapies like TMS and ketamine, can restore BDNF levels and promote neuroplasticity, essentially helping the brain to heal and rebuild itself.
The hypothalamic-pituitary-adrenal (HPA) axis, the body's central stress response system, is frequently hyperactive in depression. This leads to elevated cortisol levels, which can damage neurons, impair immune function, and disrupt sleep architecture. Additionally, growing evidence points to the role of neuroinflammation -- elevated inflammatory cytokines in the brain -- as both a contributing factor and a consequence of depression. This understanding has opened new avenues for treatment, including anti-inflammatory approaches that show promise in clinical trials.
What Causes Depression?
Depression rarely has a single cause. Rather, it typically results from a combination of genetic, biological, environmental, and psychological factors. Research indicates that depression has a heritability of approximately 37%, meaning that genetics play a meaningful but not deterministic role. Having a first-degree relative with depression increases your risk by two to three times compared to the general population.
Environmental triggers frequently precipitate depressive episodes, including major life stressors such as loss of a loved one, divorce, job loss, financial hardship, or chronic illness. Early childhood adversity, including abuse, neglect, or household dysfunction, significantly increases vulnerability to depression later in life by altering stress response systems during critical developmental periods. Chronic medical conditions such as heart disease, diabetes, cancer, and chronic pain are strongly associated with depression, creating bidirectional relationships where each condition worsens the other. Substance use, particularly alcohol and cannabis, can both trigger and worsen depressive episodes.
Signs & Symptoms of Depression
Depression manifests differently in each individual. Recognizing the signs is the critical first step toward getting effective help. A diagnosis of Major Depressive Disorder requires five or more of the following symptoms to be present during the same two-week period.
Emotional Symptoms
- ✓ Persistent feelings of sadness, emptiness, or hopelessness that do not lift with time or positive events
- ✓ Markedly diminished interest or pleasure in all, or almost all, activities (anhedonia) -- including hobbies and social interactions that were previously enjoyable
- ✓ Excessive guilt or feelings of worthlessness that are disproportionate to the situation
- ✓ Irritability, frustration, or angry outbursts over small matters (particularly common in men and adolescents)
- ✓ Recurrent thoughts of death, suicidal ideation, or suicide attempts
Physical & Cognitive Symptoms
- ✓ Significant changes in appetite or weight -- either loss or gain of more than 5% body weight in a month without intentional dieting
- ✓ Insomnia (difficulty falling or staying asleep) or hypersomnia (excessive sleeping, sometimes 12 or more hours per day)
- ✓ Fatigue or loss of energy nearly every day, often described as feeling "heavy" or physically drained
- ✓ Psychomotor agitation (restlessness) or retardation (slowed movements and speech noticeable to others)
- ✓ Diminished ability to think, concentrate, or make decisions -- often described as "brain fog"
- ✓ Unexplained physical complaints such as headaches, digestive problems, or chronic pain that do not respond to standard treatment
How We Diagnose Depression
An accurate diagnosis is the foundation of effective treatment. Our board-certified psychiatrists conduct thorough, multi-dimensional evaluations to understand your unique experience.
Comprehensive Psychiatric Evaluation
Your initial 60-to-90-minute evaluation includes a detailed review of your current symptoms, their duration and severity, and their impact on your daily life. We explore your personal and family psychiatric history, medical history, current medications, and substance use history. We also use validated screening instruments such as the PHQ-9 (Patient Health Questionnaire) and the Hamilton Depression Rating Scale (HAM-D) to quantify symptom severity and track your progress over time.
Medical Assessment & Lab Work
Several medical conditions can mimic or exacerbate depression, including thyroid disorders (hypothyroidism), vitamin deficiencies (particularly B12, folate, and vitamin D), anemia, hormonal imbalances, and chronic infections. We may order blood work and other diagnostic tests to rule out these underlying medical causes and ensure your treatment plan addresses the complete clinical picture.
Pharmacogenomic Testing
Through our pharmacogenomic testing service, we can analyze your genetic profile to predict how you will metabolize and respond to various psychiatric medications. This precision medicine approach helps us select the most effective antidepressant for your unique genetic makeup, reducing the trial-and-error approach that has traditionally characterized psychiatric prescribing and accelerating your path to symptom relief.
Differential Diagnosis
Accurate diagnosis requires distinguishing depression from conditions with overlapping symptoms, including Bipolar Disorder, Anxiety Disorders, PTSD, ADHD, and adjustment disorders. Misdiagnosis can lead to ineffective or even harmful treatment, which is why our psychiatrists take the time necessary to arrive at a precise, comprehensive diagnosis before developing your treatment plan.
Our Treatment Approach
At RECO Integrated Psychiatry, we believe in a multimodal approach to depression treatment. We combine first-line interventions with cutting-edge therapies to create a personalized plan that addresses your unique needs and offers the greatest chance of lasting recovery.
Medication Management
Our psychiatrists are experts in psychopharmacology, prescribing from the full range of antidepressant classes including SSRIs (such as sertraline, escitalopram, and fluoxetine), SNRIs (such as venlafaxine and duloxetine), atypical antidepressants (such as bupropion and mirtazapine), and augmentation strategies using atypical antipsychotics or mood stabilizers. When appropriate, we use pharmacogenomic testing to guide medication selection and dosing for optimal outcomes.
Learn MorePsychotherapy
Therapy is a cornerstone of depression treatment. We offer Cognitive Behavioral Therapy (CBT), which has the strongest evidence base for depression and helps identify and restructure negative thought patterns. We also provide Interpersonal Therapy (IPT), which focuses on improving relationship patterns and communication. For chronic depression, Behavioral Activation helps patients re-engage with meaningful activities. Research consistently shows that combining psychotherapy with medication yields better outcomes than either approach alone.
Learn MoreTMS Therapy
Transcranial Magnetic Stimulation is an FDA-cleared, non-invasive treatment that uses focused magnetic pulses to stimulate the left dorsolateral prefrontal cortex -- a brain region consistently underactive in depression. TMS is particularly effective for treatment-resistant depression, with clinical trials showing remission rates of approximately 30-37% and response rates of 50-60% in patients who have not responded to medication. Standard protocols involve daily sessions over 4-6 weeks, and newer accelerated protocols can complete treatment in as little as five days.
Learn MoreSpravato (Esketamine)
Spravato is an FDA-approved intranasal esketamine treatment for treatment-resistant depression and major depressive disorder with suicidal ideation. It works through the glutamate system rather than the traditional monoamine pathways targeted by conventional antidepressants, offering a fundamentally different mechanism of action. Administered under medical supervision in our certified treatment center, Spravato can produce rapid antidepressant effects, with many patients noticing improvement within hours to days. The treatment is typically given twice weekly initially, then tapered to weekly and biweekly sessions.
Learn MoreIV Ketamine Therapy
IV Ketamine therapy represents one of the most significant breakthroughs in depression treatment in decades. By targeting NMDA receptors in the glutamate system, ketamine rapidly promotes synaptogenesis -- the formation of new neural connections -- and increases BDNF levels. Research published in the American Journal of Psychiatry demonstrates that a single ketamine infusion can reduce depressive symptoms within hours. Our standard protocol typically involves a series of six infusions over two to three weeks, followed by maintenance infusions as needed. IV Ketamine is particularly valuable for patients with severe, treatment-resistant depression and those with acute suicidal ideation.
Learn MoreHolistic & Lifestyle Integration
We recognize that lasting recovery from depression involves more than medication and therapy sessions. Our integrated approach incorporates evidence-based lifestyle modifications including structured exercise prescriptions (shown to be as effective as antidepressants for mild-to-moderate depression), sleep hygiene optimization, nutritional guidance emphasizing anti-inflammatory diets, mindfulness and meditation training, and stress management techniques. We also address social connectivity and purpose, which research identifies as critical protective factors against depression recurrence.
Living With Depression
Living with depression is challenging, but it is important to understand that this condition is highly treatable. With proper care, the vast majority of people with depression experience significant improvement or full remission of symptoms. According to the American Psychiatric Association, between 80% and 90% of people with depression eventually respond well to treatment.
Recovery from depression is rarely linear. There will be good days and difficult days, and setbacks do not mean treatment is failing. Building a strong support system, maintaining consistent treatment engagement, and developing healthy coping strategies are all critical components of long-term wellness. We encourage our patients to engage with community resources, support groups, and psychoeducational materials to deepen their understanding of their condition and build resilience.
Our team works closely with each patient to develop a relapse prevention plan that includes identifying early warning signs, establishing an action plan for worsening symptoms, maintaining protective lifestyle habits, and scheduling regular follow-up appointments. Continuation and maintenance treatment -- continuing medication and/or therapy after symptoms have resolved -- is one of the most effective strategies for preventing recurrence, particularly for individuals who have experienced multiple depressive episodes.
When to Seek Help
If you are experiencing symptoms of depression that have persisted for more than two weeks and are interfering with your ability to work, maintain relationships, or engage in daily activities, it is time to seek professional help. You do not need to wait until symptoms become severe. Early intervention leads to better outcomes, shorter recovery times, and a reduced risk of recurrence.
Seek immediate help if you experience:
- ! Suicidal thoughts or thoughts of self-harm
- ! Psychotic symptoms such as hallucinations or delusions
- ! Inability to care for yourself or your dependents
- ! Significant substance use escalation to cope with symptoms
Crisis Resources: Call 988 (Suicide & Crisis Lifeline), text HOME to 741741, or go to your nearest emergency room. These services are available 24/7.
Frequently Asked Questions About Depression
Related Conditions
Depression frequently co-occurs with other mental health conditions. Understanding these connections is essential for comprehensive treatment.
Anxiety Disorders
Nearly 60% of people with depression also experience significant anxiety. Comorbid anxiety and depression require coordinated treatment approaches.
PTSD & Trauma
Traumatic experiences are a leading trigger for depression. Approximately half of people with PTSD also meet criteria for major depression.
Bipolar Disorder
Bipolar depression can look identical to unipolar depression but requires fundamentally different treatment. Accurate diagnosis is essential.
ADHD
Adults with ADHD are nearly three times more likely to develop depression. Treating both conditions simultaneously yields the best outcomes.
